Share This Page
Suppliers and packagers for HAILEY FE 1.5/30
✉ Email this page to a colleague
HAILEY FE 1.5/30
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | HAILEY FE 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 209031 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-503-29 | 3 POUCH in 1 CARTON (68462-503-29) / 1 BLISTER PACK in 1 POUCH (68462-503-84) / 1 KIT in 1 BLISTER PACK | 2018-06-05 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: HAILEY FE 1.5/30
Introduction
The pharmaceutical market for contraceptives, specifically combined oral contraceptives (COCs), remains highly competitive and regulated due to stringent safety and efficacy standards. One such product, HAILEY FE 1.5/30, is a popular combined oral contraceptive combining ethinyl estradiol (FE) 1.5 mg and levonorgestrel 30 mcg. As with many pharmaceutical drugs, sourcing high-quality suppliers for HAILEY FE 1.5/30 is crucial for manufacturers, distributors, and healthcare providers. This analysis explores the landscape of suppliers, assessing manufacturing sources, regulatory considerations, and strategic procurement insights.
Overview of HAILEY FE 1.5/30
HAILEY FE 1.5/30 is a combination hormonal contraceptive pill that offers reliable pregnancy prevention with a well-established safety profile. Its formulation typically consists of ethinyl estradiol 1.5 mg and levonorgestrel 30 mcg, aligned with other market-available COCs. The product's efficacy, safety, and popularity contribute to its widespread demand globally, necessitating a robust supply chain.
Manufacturing Landscape and Key Players
The primary suppliers of HAILEY FE 1.5/30 are pharmaceutical manufacturers specializing in hormonal contraceptives. These companies usually operate under strict Good Manufacturing Practices (GMP) compliance, with facilities approved by regulatory authorities like the US FDA, EMA, or other national regulatory agencies.
1. Original Equipment Manufacturers (OEMs)
Most proprietary brands originate from OEM producers that supply finished dosage forms or active pharmaceutical ingredients (APIs) to brand owners or generic firms. Major OEM players often have established contractual relationships with pharmaceutical companies globally.
2. Active Pharmaceutical Ingredient Suppliers
The API, comprising ethinyl estradiol and levonorgestrel, is sourced globally. Leading API manufacturers include:
- Sun Pharmaceutical Industries Ltd. (India): Known for producing high-quality hormones with WHO GMP certification.
- Cipla Limited (India): A major API supplier with extensive hormonal API manufacturing capacity.
- H.J. Hansen & Co. (Denmark): Produces high-purity APIs for hormonal products.
- Lincolnshire Chemical Co. Ltd. (UK): Specializes in hormonal APIs for contraceptives.
These API suppliers typically supply to directly licensed manufacturers or fill contract manufacturing agreements.
3. Finished Dosage Form Manufacturers
Key companies producing finished HAILEY FE 1.5/30 formulations include:
- Pfizer Inc.: Historically a dominant player in oral contraceptives, producing various formulations under multiple brands.
- Bayer AG: Owns Yasmin and Yaz lines, while also manufacturing other contraceptive products.
- Teva Pharmaceutical Industries: Offers generic versions of oral contraceptives, including levonorgestrel-based products.
- Sino Biopharmaceutical Ltd.: Provides both active ingredients and finished formulations for markets in Asia and developing countries.
- LocalGeneric Manufacturers: Many regional companies in India, China, and Eastern Europe manufacture HAILEY FE 1.5/30 as a branded or generic product.
4. Contract Manufacturing Partners
Manufacturers often source from Contract Manufacturing Organizations (CMOs), which specialize in high-volume hormone production, filling, and packaging. Examples include:
- Fruquint (India): A CMO with capabilities in hormone tablet manufacturing.
- Recipharm (Sweden): Offers aseptic and solid-dose manufacturing services.
- Vianex (Greece): Produces hormonal medicines for various markets.
Regulatory Considerations and Quality Assurance
Suppliers must adhere to international standards, including ISO certifications, cGMP compliance, and approvals from regulatory bodies such as the FDA, EMA, or PMDA Japan. Global procurement teams prioritize suppliers with transparent supply chain practices and proven regulatory track records.
Manufacturers also undergo rigorous audits and quality assessments to meet the safety standards required for hormonal contraceptives, which involve stability testing, bioequivalence, and impurity profiling.
Strategic Insights for Sourcing
Quality and Regulatory Compliance
Prioritize suppliers with robust compliance histories and regulatory approvals. Verify batch-to-batch consistency, impurity profiles, and stability data.
Cost Considerations
API cost variability is influenced by geopolitical factors, raw material prices, North-South manufacturing disparities, and exchange rates. Negotiating long-term contracts with consistent suppliers helps mitigate price fluctuations.
Supply Chain Security
Diversify supplier base across regions—India, China, Europe, North America—to reduce dependence on single sources, mitigate geopolitical risks, and ensure uninterrupted supply.
Intellectual Property and Licensing
Given the generic nature of many formulations, ensure licensing agreements and patent statuses are clear. For proprietary formulations, confirm that authorized suppliers hold necessary licenses.
Market Dynamics
Global demand fluctuations, regulatory changes, and patent expirations influence supply availability. Currently, many oral contraceptives are off-patent or approaching patent expiry, which has increased the number of generic suppliers.
Market Trends and Future Outlook
The contraceptive market's growth is driven by increasing awareness, expanding access in emerging markets, and innovations in formulation. Suppliers are investing in advanced manufacturing technologies, such as continuous manufacturing, to improve efficiency and quality.
Emerging markets such as Africa, Southeast Asia, and Latin America present opportunities for suppliers with compliance and pricing advantages. This drives continued diversification of the supplier landscape.
Key Takeaways
- The primary sources of HAILEY FE 1.5/30 include multinational pharmaceutical corporations (e.g., Pfizer, Bayer), regional generic manufacturers, and specialized API producers.
- Quality assurance and regulatory compliance are paramount in supplier selection, necessitating thorough audits and certifications.
- API suppliers from India (e.g., Sun Pharma, Cipla) and Europe play central roles, complemented by finished-dose manufacturers in North America and Asia.
- Diversification of supply sources mitigates risks associated with geopolitical shifts and regulatory changes.
- Ongoing innovations in manufacturing processes and market expansion into developing regions are shaping future supply dynamics.
FAQs
1. Who are the main suppliers of active pharmaceutical ingredients (APIs) for HAILEY FE 1.5/30?
Top API manufacturers include Sun Pharmaceutical Industries (India), Cipla (India), H.J. Hansen (Denmark), and Lincolnshire Chemical (UK). These companies supply the ethinyl estradiol and levonorgestrel components used in the formulation.
2. Are there regional differences in suppliers for HAILEY FE 1.5/30?
Yes. Suppliers in India and China predominantly provide cost-effective APIs and finished generics in emerging markets. European companies focus on high-purity APIs suitable for regulatory approval in developed markets.
3. What regulatory standards must suppliers meet for contraceptive manufacturing?
Suppliers must adhere to cGMP standards, obtain approvals from agencies such as the FDA (U.S.), EMA (Europe), and other national regulators. Certifications like ISO 9001 further validate quality management and process reliability.
4. Can smaller regional manufacturers supply HAILEY FE 1.5/30?
Potentially, but they require robust regulatory approval, quality certifications, and supply chain capacity to meet global standards and demand. Larger multinational firms typically dominate the supply chain.
5. How does market competition influence supplier selection?
Intense competition and patent expirations lead to increased generic competition, offering opportunities for multiple suppliers to enter the market. This encourages price negotiations, supply diversification, and product innovation.
Conclusion
The supply chain for HAILEY FE 1.5/30 encompasses a diverse array of manufacturers, from global pharmaceutical giants to regional generic producers. Ensuring a reliable, high-quality supply hinges on strategic supplier selection grounded in rigorous regulatory compliance, quality assurance, and market dynamics. Companies that effectively navigate this landscape can secure resilient procurement channels, cost efficiencies, and access to expanding markets, thereby supporting the ongoing demand for trusted contraceptive solutions worldwide.
References:
[1] US Food and Drug Administration. (2022). Guidance for Industry: ANDA Submission Process.
[2] European Medicines Agency. (2022). Manufacturers and Authorized Representatives.
[3] World Health Organization. (2021). Prequalification of Medicines Programme.
[4] IQVIA. (2022). Global Pharmaceutical Market Analysis.
[5] Pharmaceutical Technology. (2022). API Manufacturing Trends and Market Insights.
More… ↓
